54 related articles for article (PubMed ID: 1656434)
1. Estrogen receptors in skin appendage tumors and extramammary Paget's disease.
Lloveras B; Googe PB; Goldberg DE; Bhan AK
Mod Pathol; 1991 Jul; 4(4):487-90. PubMed ID: 1656434
[TBL] [Abstract][Full Text] [Related]
2. Extramammary Paget disease is characterized by the consistent lack of estrogen and progesterone receptors but frequently expresses androgen receptor.
Diaz de Leon E; Carcangiu ML; Prieto VG; McCue PA; Burchette JL; To G; Norris BA; Kovatich AJ; Sanchez RL; Krigman HR; Gatalica Z
Am J Clin Pathol; 2000 Apr; 113(4):572-5. PubMed ID: 10761460
[TBL] [Abstract][Full Text] [Related]
3. Comparison of two antibodies for evaluation of estrogen receptors in paraffin-embedded tumors.
Hendricks JB; Wilkinson EJ
Mod Pathol; 1993 Nov; 6(6):765-70. PubMed ID: 7508117
[TBL] [Abstract][Full Text] [Related]
4. [An immunohistochemical analysis of extramammary Paget's disease compared with mammary Paget's disease].
Hasebe T; Yamamichi N; Konishi F; Mukawa A
Gan No Rinsho; 1988 Feb; 34(2):159-66. PubMed ID: 2831411
[TBL] [Abstract][Full Text] [Related]
5. Study of neu-protein expression in mammary Paget's disease with and without underlying breast carcinoma and in extramammary Paget's disease.
Meissner K; Rivière A; Haupt G; Löning T
Am J Pathol; 1990 Dec; 137(6):1305-9. PubMed ID: 1701961
[TBL] [Abstract][Full Text] [Related]
6. Immunologic characteristics of keratins in extramammary Paget's disease.
Tazawa T; Ito M; Fujiwara H; Shimizu N; Sato Y
Arch Dermatol; 1988 Jul; 124(7):1063-8. PubMed ID: 2455483
[TBL] [Abstract][Full Text] [Related]
7. [Immunohistochemical studies of breast and extra-mammary Paget's disease indicate an apocrine differentiation].
Lautier R; Achtelik WV; Wolff HH
Z Hautkr; 1990 Jun; 65(6):571-4. PubMed ID: 2167569
[TBL] [Abstract][Full Text] [Related]
8. Expression of ras p21 in mammary and extramammary Paget's disease.
Mori O; Hachisuka H; Nakano S; Sasai Y; Shiku H
Arch Pathol Lab Med; 1990 Aug; 114(8):858-61. PubMed ID: 1695839
[TBL] [Abstract][Full Text] [Related]
9. Estrogen and progesterone receptors and anti-gross cystic disease fluid protein 15 (BRST-2) fail to distinguish metastatic breast carcinoma from eccrine neoplasms.
Wallace ML; Longacre TA; Smoller BR
Mod Pathol; 1995 Dec; 8(9):897-901. PubMed ID: 8751328
[TBL] [Abstract][Full Text] [Related]
10. Alopecia neoplastica due to metastatic breast carcinoma vs. extramammary Paget's disease: mimicry in epidermotropic carcinoma.
Haas N; Hauptmann S
J Eur Acad Dermatol Venereol; 2004 Nov; 18(6):708-10. PubMed ID: 15482303
[TBL] [Abstract][Full Text] [Related]
11. Eccrine sweat gland carcinoma of the scrotum with associated extramammary Paget's disease.
Saidi JA; Bose S; Sawczuk IS
Urology; 1997 Nov; 50(5):789-91. PubMed ID: 9372896
[TBL] [Abstract][Full Text] [Related]
12. Extramammary Paget's disease of the axilla: an unusual case.
Chagpar AB; Heim K; Carron KR; Sewell C
Breast J; 2007; 13(3):291-3. PubMed ID: 17461905
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical detection of estrogen and progesterone receptors performed with an antigen-retrieval technique on methacarn-fixed paraffin-embedded breast cancer tissues.
Oyaizu T; Arita S; Hatano T; Tsubura A
J Surg Res; 1996 Jan; 60(1):69-73. PubMed ID: 8592434
[TBL] [Abstract][Full Text] [Related]
14. Extramammary Paget's disease. Arising in knee region in association with sweat gland carcinoma.
de Blois GG; Patterson JW; Hunter SB
Arch Pathol Lab Med; 1984 Sep; 108(9):713-6. PubMed ID: 6205637
[TBL] [Abstract][Full Text] [Related]
15. Expression of prostate-specific antigen and androgen receptor in extramammary Paget's disease and carcinoma.
Inoguchi N; Matsumura Y; Kanazawa N; Morita K; Tachibana T; Sakurai T; Utani A; Miyachi Y
Clin Exp Dermatol; 2007 Jan; 32(1):91-4. PubMed ID: 17163959
[TBL] [Abstract][Full Text] [Related]
16. Extramammary Paget's disease--a proliferation of adnexal origin?
Regauer S
Histopathology; 2006 May; 48(6):723-9. PubMed ID: 16681689
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor immunocytochemical assay (ER-ICA): computerized image analysis system, immunoelectron microscopy, and comparisons with estradiol binding assays in 115 breast carcinomas.
Charpin C; Martin PM; Jacquemier J; Lavaut MN; Pourreau-Schneider N; Toga M
Cancer Res; 1986 Aug; 46(8 Suppl):4271s-4277s. PubMed ID: 3524808
[TBL] [Abstract][Full Text] [Related]
18. Concordant over-expression of transcription factor Sp1 and vascular endothelial growth factor in extramammary Paget's disease.
Chen SY; Takeuchi S; Moroi Y; Hayashida S; Kido M; Uchi H; Takahara M; Uenotsuchi T; Tu YT; Urabe K; Furue M
Int J Dermatol; 2008 Jun; 47(6):562-6. PubMed ID: 18477144
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor immunocytochemistry in paraffin embedded tissues with ER1D5 predicts breast cancer endocrine response more accurately than H222Sp gamma in frozen sections or cytosol-based ligand-binding assays.
Pertschuk LP; Feldman JG; Kim YD; Braithwaite L; Schneider F; Braverman AS; Axiotis C
Cancer; 1996 Jun; 77(12):2514-9. PubMed ID: 8640700
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor, estrogen, and progesterone receptor expression in primary sweat gland carcinomas and primary and metastatic mammary carcinomas.
Busam KJ; Tan LK; Granter SR; Kohler S; Junkins-Hopkins J; Berwick M; Rosen PP
Mod Pathol; 1999 Aug; 12(8):786-93. PubMed ID: 10463481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
